Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-22-001313
Filing Date
2022-02-01
Accepted
2022-02-01 18:30:03
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27687
2 filename2.txt TEXT-EXTRACT 1517
  Complete submission text file 0000000000-22-001313.txt   40246
Mailing Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601
Business Address 180 N. LASALLE STREET, SUITE 1600 CHICAGO IL 60601 844-445-5704
Xeris Biopharma Holdings, Inc. (Filed for) CIK: 0001867096 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations